➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Dow
Medtronic
Moodys
McKesson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Litigation Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-02-22
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To Christopher J. Burke
Parties TEVA PHARMACEUTICALS USA, INC.
Patents 10,004,729; 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813; 8,840,928; 9,044,398; 9,248,195; 9,592,200; 9,682,075; 9,737,530; 9,763,883; 9,968,598
Attorneys Oren D. Langer
Firms Richards, Layton & Finger, PA
Link to Docket External link to docket
Small Molecule Drugs cited in Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-02-22 1 before the expiration of, Collegium’s U.S. Patents Nos. 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813…is an action for relief from patent infringement, arising under the patent laws of Title 35, United States…Notice of Patent Certification asserting it intends to launch its copy before Collegium’s patents to its…of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). …of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). External link to document
2019-09-11 107 Report and Recommendations #39;"883 patent"), 9,968,598 (the '"598 patent") and 10,004,729 (the '"…infringement of 13 patents: United States Patent Nos. 7,771,707 (the "'707 patent"), 8,449,…quot;729 patent" and collectively with the other patents, "the asserted patents"). Presently…,909 (the "'909 patent"), 8,557,291 (the "'291 patent"), 8,758,813 (the &… "'813 patent"), 8,840,928 (the '"928 patent"), 9,044,398 (the '" External link to document
2018-02-22 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,771,707 B2; US 8,449,909 …22 February 2018 1:18-cv-00300 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Boehringer Ingelheim
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.